Youngjoo Lee
Biomedicine Production Branch
Goyang, Republic of Korea
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Early On-Treatment Host Fitness Dynamics Refine Prognostic Stratification in Advanced NSCLC Receiving First-Line Immunotherapy.
Journal: Cancer research and treatment
Published: June 07, 2026
Central Nervous System Activity of Lazertinib in EGFR-Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG-LU20-15 and LU21-01.
Journal: Thoracic cancer
Published: June 03, 2026
A real-world Fitbit-derived dataset of activity, sleep, and heart rate with matched clinical factors in on-treatment lung cancer patients.
Journal: Scientific data
Published: February 10, 2026
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.
Journal: Nature medicine
Published: January 29, 2026
Adaptive reinforcement learning for energy-efficient high-recovery closed-circuit reverse osmosis.
Journal: Water research
Published: December 17, 2025
Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: November 26, 2025
Demographic and behavioral correlation of red ginseng consumption in Korea.
Journal: Integrative medicine research
Published: August 21, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 17, 2025
Central Nervous System Outcomes of Lazertinib Treatment in EGFR-Mutated Advanced NSCLC: Pooled Analysis From LASER201 and LASER301.
Journal: Clinical lung cancer
Published: May 30, 2025
Fibroblast TGF-β signaling defines spatial tumor ecosystems linked to immune checkpoint blockade resistance.
Journal: Communications biology
Published: May 24, 2025
Overcoming MET-targeted drug resistance in MET-amplified lung cancer by aurora kinase B inhibition.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: January 22, 2025
VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.
Journal: MedComm
Published: December 30, 2024
Last Updated: 09/26/2026